Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cefazolin vs Vancomycin for Infection Prevention in Closed Fractures
NCT02027532Terminated
- Sponsor
- University of Tennessee
- Start
- Oct 2009
- Primary completion
- Jun 2015
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
- Countries
- 1
01
Overview
Randomised trial of vancomycin in surgical site infection (SSI), sponsored by University of Tennessee. Primary endpoint: Incidence of infection at 1 year. Started Oct 2009; status: terminated.
02
Drugs
vancomycin
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT02027532.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02027532.